OBJECTIVE: To assess the suitability of using oral-fluid samples for determining the prevalence of immunity to vaccine-preventable infections. METHODS: Paired blood and oral-fluid samples were obtained from 853 individuals of all ages from a rural Ethiopian community. Oral fluid around the gums was screened for measles- and rubella-specific antibodies using enhanced IgG antibody capture (GAC) enzyme-linked immunosorbent assays (ELISAs), and for anti-HBc antibodies using a prototype GACELISA. IgG antibodies in serum to measles, rubella and HBc were determined using commercial ELISAs. FINDINGS: Relative to serum, oral fluid assay sensitivity and specificity were as follows: 98% and 87% for measles, 79% and 90% for rubella, and 43% and 87% for anti-HBc. These assay characteristics yielded population prevalence estimates from oral fluid with a precision equal to that of serum for measles (all ages) and rubella (ages < 20 years). CONCLUSION: Our results suggest that oral fluid could have the potential to replace serum in IgG antibody prevalence surveys. Further progress requires assessment of variation in assay performance between populations as well as the availability of standardized, easy to use assays.
OBJECTIVE: To assess the suitability of using oral-fluid samples for determining the prevalence of immunity to vaccine-preventable infections. METHODS: Paired blood and oral-fluid samples were obtained from 853 individuals of all ages from a rural Ethiopian community. Oral fluid around the gums was screened for measles- and rubella-specific antibodies using enhanced IgG antibody capture (GAC) enzyme-linked immunosorbent assays (ELISAs), and for anti-HBc antibodies using a prototype GACELISA. IgG antibodies in serum to measles, rubella and HBc were determined using commercial ELISAs. FINDINGS: Relative to serum, oral fluid assay sensitivity and specificity were as follows: 98% and 87% for measles, 79% and 90% for rubella, and 43% and 87% for anti-HBc. These assay characteristics yielded population prevalence estimates from oral fluid with a precision equal to that of serum for measles (all ages) and rubella (ages < 20 years). CONCLUSION: Our results suggest that oral fluid could have the potential to replace serum in IgG antibody prevalence surveys. Further progress requires assessment of variation in assay performance between populations as well as the availability of standardized, easy to use assays.
Authors: K Vainio; H H Samdal; G Anestad; E Wedege; D H Skutlaberg; K T Bransdal; R Mundal; I S Aaberge Journal: Eur J Clin Microbiol Infect Dis Date: 2008-02-22 Impact factor: 3.267
Authors: Holly R Hughes; Amy L Vincent; Susan L Brockmeier; Phillip C Gauger; Lindomar Pena; Jefferson Santos; Douglas R Braucher; Daniel R Perez; Crystal L Loving Journal: Clin Vaccine Immunol Date: 2015-08-19
Authors: Nana O Wilson; Andrew A Adjei; Winston Anderson; Stella Baidoo; Jonathan K Stiles Journal: Am J Trop Med Hyg Date: 2008-05 Impact factor: 2.345
Authors: Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden Journal: Antiviral Res Date: 2002-08 Impact factor: 5.970
Authors: Swinburne A J Augustine; Tarsha N Eason; Kaneatra J Simmons; Shannon M Griffin; Clarissa L Curioso; Malini K D Ramudit; Elizabeth A Sams; Kevin H Oshima; Alfred Dufour; Timothy J Wade Journal: J Clin Microbiol Date: 2020-09-22 Impact factor: 5.948
Authors: Ali Rowhani-Rahbar; Joseph J Carter; Stephen E Hawes; James P Hughes; Noel S Weiss; Denise A Galloway; Laura A Koutsky Journal: J Infect Dis Date: 2009-11-01 Impact factor: 5.226
Authors: Jagrati V Jani; Carol Holm-Hansen; Tufária Mussá; Arlinda Zango; Ivan Manhiça; Gunnar Bjune; Ilesh V Jani Journal: BMC Public Health Date: 2008-11-12 Impact factor: 3.295